Home | Top News | World | US News | Politics | Economy | Sports | Technology | Science | Lifestyle | People | Recalls

American Health Packaging Issues Voluntary Nationwide Recall of Valsartan Tablets Due to the Detection of NDEA (N-Nitrosodiethylamine) Impurity


American Health Packaging is voluntarily recalling one lot of Valsartan Tablets, USP, 160 mg to the consumer level due to the detection of trace amounts of an unexpected impurity found in the finished drug product. The impurity detected in the finished drug product is N-Nitrosodiethylamine (NDEA), which is a substance that occurs naturally in certain foods, drinking water, air pollution, and industrial processes, and has been classified as a probable human carcinogen as per International Agency for Research on Cancer (IARC) classification. This recall is being initiated in response to the recall by the manufacturer (Aurobindo Pharma USA, Inc.), which included the affected lot that was repackaged by American Health Packaging. (US Food Recalls) More More

Similar stories

Voluntary Recall Issued for Popular High Blood Pressure Medication - SCVNEWS.com

Voluntary Recall Issued for Popular High Blood Pressure Medication  SCVNEWS.com

American Health Packaging is voluntarily recalling one lot of Valsartan Tablets, USP, 160 mg to the consumer level due to the detection of trace amounts of an ...

Posted on 14 March 2019 | 10:00 am | Google News

American Health Packaging Issues Voluntary Nationwide Recall of Valsartan Tablets Due to the - WSOC Charlotte

American Health Packaging Issues Voluntary Nationwide Recall of Valsartan Tablets Due to the  WSOC Charlotte

American Health Packaging is voluntarily recalling one lot of Valsartan Tablets, USP, 160 mg to the consumer level due to the detection of trace amounts of an ...

Posted on 7 March 2019 | 3:00 am | Google News

AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 38 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity. - US Recall News

AurobindoPharma USA, Inc. Initiates a Voluntary Nationwide Consumer Level Recall Expansion of 38 Lots of Amlodipine Valsartan Tablets USP and Valsartan Tablets, USP due to the detection of NDEA (N-Nitrosodiethylamine) Impurity.  US Recall News

AurobindoPharma USA, Inc. is conducting a voluntary recall expansion of 38 lots of Valsartan and Amlodipine and Valsartan tablets to the consumer level due to ...

Posted on 1 March 2019 | 3:00 am | Google News

Recalls That Should Be on Your Radar-Week of February 24, 2019 - Contagionlive.com

Recalls That Should Be on Your Radar-Week of February 24, 2019  Contagionlive.com

We've rounded up a list of important US Food and Drug Administration and US Department of Agriculture recalls from this past week.

Posted on 24 February 2019 | 3:00 am | Google News

BLOOD PRESSURE MEDICINE CANCER RISK: More than a dozen blood pressure medications recalled since July - WPXI Pittsburgh

BLOOD PRESSURE MEDICINE CANCER RISK: More than a dozen blood pressure medications recalled since July  WPXI Pittsburgh

PITTSBURGH - Another day, another problem for blood pressure medications, and it's starting to frustrate Cindy Bryan who takes her pills daily. "Even the ...

Posted on 1 February 2019 | 3:00 am | Google News

Valsartan, Losartan and Other Blood Pressure Medication Recalls 2018-19 - WebMD

Valsartan, Losartan and Other Blood Pressure Medication Recalls 2018-19  WebMD

Note: This story was updated on March 18, 2019 with the recall of 43 lots of Losartan. Dozens of medications used to treat high blood pressure have been ...

Posted on 23 January 2019 | 5:48 am | Google News

Copyright © 2019 LastMinuteStuff.com
Contact info